Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Goodrx Holdings Inc Cl A
(NQ:
GDRX
)
7.545
+0.075 (+1.00%)
Streaming Delayed Price
Updated: 10:37 AM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Goodrx Holdings Inc Cl A
< Previous
1
2
3
4
5
Next >
GDRX Alert: Rosen, Skilled Investor Counsel, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
April 23, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
GDRX INVESTOR ALERT: Kessler Topaz Meltzer & Check, LLP Files A Securities Fraud Class Action Lawsuit Against GoodRX Holdings, Inc. And Encourages Investors With Losses To Contact The Firm
April 22, 2024
From
Kessler Topaz Meltzer & Check, LLP
Via
Business Wire
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio
Via
MarketBeat
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
April 11, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Interim CEO Extends Commitment to Company
March 14, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Reports Fourth Quarter and Full Year 2023 Results
February 29, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
This healthcare stock making a buzz with 160% growth
February 26, 2024
Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them.
Via
MarketBeat
Topics
Economy
Exposures
Economy
GoodRx to Participate in Upcoming Investor Conferences
February 20, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
Gene therapy: Why does it cost millions for a single treatment?
February 15, 2024
Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology.
Via
MarketBeat
Exposures
Product Safety
GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
February 01, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces Proposed Refinancing of First Lien Credit Facilities
January 22, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings
January 11, 2024
From
GoodRx
Via
Business Wire
GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024
January 10, 2024
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Appoints Kelly J. Kennedy to Board of Directors
December 22, 2023
From
GoodRx
Via
Business Wire
GoodRx to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
December 13, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx to Participate in the Evercore ISI HealthCONx Conference
November 16, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Reports Third Quarter 2023 Results
November 09, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Announces New Way for Consumers to Access Sanofi’s Lantus for $35 at Over 70,000 Pharmacies Nationwide
October 19, 2023
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Third Quarter 2023 Earnings Release and Conference Call
October 12, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx and Navitus Health Solutions Announce Savings Connect Program to Deliver Lower Prescription Prices for Navitus Members
October 12, 2023
From
GoodRx
Via
Business Wire
GoodRx Announces Significant Savings on Antivirals, Medications and Vaccines for Cold & Flu Season
September 21, 2023
From
GoodRx
Via
Business Wire
GoodRx and MedImpact Announce Program to Ensure Seamless Access to Affordable Prescriptions
September 13, 2023
From
GoodRx
Via
Business Wire
GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens
September 11, 2023
From
GoodRx
Via
Business Wire
GoodRx to Present at the Morgan Stanley Global Healthcare Conference
August 30, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
GoodRx Launches Real-Time Benefit Check In Provider Mode To Offer Comprehensive Cost Information At The Point of Prescribing
August 30, 2023
From
GoodRx
Via
Business Wire
GoodRx Reports Second Quarter 2023 Results
August 09, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
More Good News Coming? GoodRx Spikes Ahead of Q2 Earnings
August 08, 2023
With newfound business momentum and consensus EPS that's been topped in five straight quarters, GDRX could deliver a report shareholders have been waiting for.
Via
MarketBeat
Topics
Initial Public Offering
Exposures
Securities Market
GoodRx Holdings Inc. (NASDAQ: GDRX) Leading the Way in Monday Trading Based on Percentage Gain
July 31, 2023
Via
Investor Brand Network
GoodRx Unveils Medicine Cabinet, A Better Way To Manage All Of Your Prescriptions
July 27, 2023
From
GoodRx
Via
Business Wire
GoodRx Announces Date for Second Quarter 2023 Earnings Release and Conference Call
July 12, 2023
From
GoodRx Holdings, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.